 Kimberly Simmons
Concepts (115)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetes Mellitus, Type 1 | 22 | 2023 | 3252 | 3.290 |
Why?
| | Autoantibodies | 9 | 2023 | 1346 | 1.790 |
Why?
| | Insulin-Secreting Cells | 5 | 2023 | 317 | 1.710 |
Why?
| | Diet, Carbohydrate-Restricted | 1 | 2021 | 28 | 0.730 |
Why?
| | Diet, Ketogenic | 1 | 2021 | 33 | 0.730 |
Why?
| | Prediabetic State | 1 | 2023 | 219 | 0.720 |
Why?
| | HLA-DQ beta-Chains | 1 | 2020 | 57 | 0.690 |
Why?
| | Insulin | 5 | 2023 | 2079 | 0.690 |
Why?
| | Health Fairs | 1 | 2019 | 9 | 0.670 |
Why?
| | Autoimmunity | 3 | 2023 | 813 | 0.580 |
Why?
| | Celiac Disease | 2 | 2022 | 264 | 0.570 |
Why?
| | Dried Blood Spot Testing | 1 | 2016 | 71 | 0.530 |
Why?
| | Insulin Antibodies | 1 | 2016 | 102 | 0.520 |
Why?
| | HLA-D Antigens | 1 | 2014 | 34 | 0.470 |
Why?
| | Diet Therapy | 1 | 2014 | 36 | 0.470 |
Why?
| | Antibodies | 1 | 2015 | 371 | 0.440 |
Why?
| | Child | 16 | 2023 | 18414 | 0.420 |
Why?
| | Adolescent | 14 | 2023 | 17844 | 0.420 |
Why?
| | Mass Screening | 1 | 2019 | 1004 | 0.410 |
Why?
| | Bone Density | 1 | 2015 | 432 | 0.390 |
Why?
| | Blood Glucose | 1 | 2020 | 1828 | 0.380 |
Why?
| | Immunosuppressive Agents | 1 | 2014 | 646 | 0.350 |
Why?
| | Endocrinology | 2 | 2022 | 70 | 0.340 |
Why?
| | Islets of Langerhans | 3 | 2023 | 726 | 0.330 |
Why?
| | Diabetes Complications | 2 | 2022 | 211 | 0.320 |
Why?
| | Hypoglycemic Agents | 2 | 2023 | 1013 | 0.310 |
Why?
| | Humans | 26 | 2023 | 114686 | 0.310 |
Why?
| | Child, Preschool | 7 | 2023 | 9116 | 0.310 |
Why?
| | Risk Assessment | 3 | 2023 | 2968 | 0.280 |
Why?
| | Infant | 7 | 2023 | 7963 | 0.270 |
Why?
| | Antibodies, Monoclonal, Humanized | 2 | 2023 | 663 | 0.250 |
Why?
| | Disease Progression | 4 | 2023 | 2380 | 0.230 |
Why?
| | Male | 9 | 2020 | 55596 | 0.180 |
Why?
| | Age of Onset | 2 | 2019 | 446 | 0.180 |
Why?
| | Obesity Management | 1 | 2020 | 8 | 0.180 |
Why?
| | Quality of Life | 2 | 2023 | 2353 | 0.180 |
Why?
| | Female | 9 | 2020 | 59507 | 0.170 |
Why?
| | Diagnostic Techniques, Endocrine | 1 | 2019 | 14 | 0.170 |
Why?
| | Clinical Protocols | 1 | 2021 | 233 | 0.170 |
Why?
| | Blood Specimen Collection | 1 | 2019 | 31 | 0.170 |
Why?
| | Glucose Tolerance Test | 1 | 2020 | 343 | 0.160 |
Why?
| | Methylation | 1 | 2019 | 208 | 0.160 |
Why?
| | Nutritional Status | 1 | 2021 | 287 | 0.160 |
Why?
| | Haplotypes | 1 | 2020 | 448 | 0.150 |
Why?
| | Cell Death | 1 | 2019 | 323 | 0.150 |
Why?
| | Community Health Services | 1 | 2019 | 212 | 0.140 |
Why?
| | Disease Susceptibility | 1 | 2019 | 316 | 0.140 |
Why?
| | Alleles | 1 | 2020 | 789 | 0.140 |
Why?
| | Hypophosphatemia | 1 | 2017 | 15 | 0.140 |
Why?
| | Influenza, Human | 1 | 2022 | 546 | 0.140 |
Why?
| | Controlled Clinical Trials as Topic | 1 | 2016 | 27 | 0.140 |
Why?
| | Radioimmunoassay | 1 | 2016 | 162 | 0.140 |
Why?
| | Risk | 1 | 2019 | 812 | 0.140 |
Why?
| | Disease Management | 1 | 2020 | 560 | 0.140 |
Why?
| | Patient Reported Outcome Measures | 1 | 2019 | 250 | 0.140 |
Why?
| | Young Adult | 3 | 2020 | 10469 | 0.130 |
Why?
| | Bone Diseases | 1 | 2017 | 57 | 0.130 |
Why?
| | Patient Education as Topic | 1 | 2021 | 680 | 0.130 |
Why?
| | Infant Formula | 1 | 2017 | 74 | 0.130 |
Why?
| | Practice Guidelines as Topic | 1 | 2023 | 1395 | 0.130 |
Why?
| | Blood Glucose Self-Monitoring | 1 | 2019 | 505 | 0.120 |
Why?
| | Abatacept | 1 | 2014 | 40 | 0.120 |
Why?
| | Diabetic Nephropathies | 1 | 2017 | 234 | 0.120 |
Why?
| | Vitamin B Complex | 1 | 2014 | 38 | 0.120 |
Why?
| | Niacinamide | 1 | 2014 | 63 | 0.110 |
Why?
| | Pediatric Obesity | 1 | 2020 | 488 | 0.110 |
Why?
| | Early Medical Intervention | 1 | 2014 | 52 | 0.110 |
Why?
| | Health Status | 1 | 2019 | 722 | 0.110 |
Why?
| | Colorado | 2 | 2023 | 4099 | 0.110 |
Why?
| | Immunoconjugates | 1 | 2014 | 87 | 0.110 |
Why?
| | Secondary Prevention | 1 | 2014 | 222 | 0.110 |
Why?
| | Chronic Disease | 1 | 2019 | 1578 | 0.100 |
Why?
| | Autoantigens | 1 | 2015 | 396 | 0.100 |
Why?
| | Primary Prevention | 1 | 2014 | 172 | 0.100 |
Why?
| | B-Lymphocytes | 1 | 2017 | 766 | 0.100 |
Why?
| | Autoimmune Diseases | 1 | 2014 | 382 | 0.090 |
Why?
| | Pediatrics | 1 | 2018 | 980 | 0.090 |
Why?
| | Risk Factors | 1 | 2023 | 8632 | 0.090 |
Why?
| | Biomarkers | 1 | 2019 | 3408 | 0.080 |
Why?
| | Adult | 3 | 2020 | 30550 | 0.080 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2014 | 1214 | 0.080 |
Why?
| | Middle Aged | 2 | 2020 | 26737 | 0.080 |
Why?
| | Consensus | 2 | 2022 | 537 | 0.080 |
Why?
| | Sensitivity and Specificity | 2 | 2022 | 1692 | 0.070 |
Why?
| | Genetic Predisposition to Disease | 1 | 2014 | 2086 | 0.070 |
Why?
| | Receptors, Antigen, T-Cell | 2 | 2022 | 615 | 0.060 |
Why?
| | Cross-Sectional Studies | 1 | 2015 | 4409 | 0.060 |
Why?
| | Infant, Newborn | 1 | 2015 | 5047 | 0.060 |
Why?
| | CD3 Complex | 1 | 2023 | 92 | 0.050 |
Why?
| | C-Peptide | 1 | 2023 | 138 | 0.050 |
Why?
| | T-Lymphocytes | 2 | 2023 | 1737 | 0.050 |
Why?
| | Seroepidemiologic Studies | 1 | 2023 | 138 | 0.050 |
Why?
| | Perception | 1 | 2023 | 311 | 0.050 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 1 | 2022 | 309 | 0.050 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2022 | 439 | 0.040 |
Why?
| | Antibodies, Viral | 1 | 2023 | 520 | 0.040 |
Why?
| | Double-Blind Method | 1 | 2023 | 1660 | 0.040 |
Why?
| | Aged | 1 | 2016 | 19074 | 0.040 |
Why?
| | ROC Curve | 1 | 2019 | 442 | 0.040 |
Why?
| | International Cooperation | 1 | 2018 | 171 | 0.040 |
Why?
| | Anxiety | 1 | 2023 | 840 | 0.040 |
Why?
| | Rickets | 1 | 2017 | 6 | 0.040 |
Why?
| | Prevalence | 1 | 2023 | 2251 | 0.030 |
Why?
| | Phosphorus | 1 | 2017 | 82 | 0.030 |
Why?
| | Alkaline Phosphatase | 1 | 2017 | 143 | 0.030 |
Why?
| | Parents | 1 | 2023 | 1186 | 0.030 |
Why?
| | Societies, Medical | 1 | 2018 | 664 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2019 | 1796 | 0.030 |
Why?
| | HLA Antigens | 1 | 2015 | 225 | 0.030 |
Why?
| | Longitudinal Studies | 1 | 2019 | 2387 | 0.030 |
Why?
| | Calcium | 1 | 2017 | 1108 | 0.020 |
Why?
| | Practice Patterns, Physicians' | 1 | 2018 | 1177 | 0.020 |
Why?
| | Prospective Studies | 1 | 2019 | 6220 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2019 | 4623 | 0.020 |
Why?
| | Animals | 1 | 2015 | 31706 | 0.010 |
Why?
|
|
Simmons's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|